Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy.

I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation)

Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation). Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy.. 4106

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009

The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007


The changes of nitric oxide metabolism and soluble forms of differentiated antigens levels in exhaled breath condensate (EBC) in Chernobyl clean-up workers with COPD
Source: Annual Congress 2009 - Occupational exposures and disease II
Year: 2009

Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways?
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 55s
Year: 2007

The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 369s
Year: 2006

Exhaled nitric oxide and exhaled breath condensate pH in smoking asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001